Evotec Se - Adr logo

Evotec Se - Adr Share Price (NASDAQ: EVO)

$3.98

-0.19

(-4.56%)

Live

Last updated on 01 Aug 2025, 01:29 AM IST

Check the interactive Evotec Se - Adr Stock chart to analyse performance

Evotec Se - Adr stock performance

as on 01 Aug 2025, 01:29 AM IST

  • Today's Low: $3.98
    Today's High: $4.06

    Day's Volatility :1.97%

  • 52 Weeks Low: $2.84
    52 Weeks High: $5.64

    52 Weeks Volatility :49.65%

Evotec Se - Adr Stock Returns

PeriodEvotec Se - AdrSector (Health Care)Index (Russel 2000)
3 Months
-1.18%
-4.5%
0.0%
6 Months
-6.9%
-8.6%
0.0%
1 Year
-12.18%
-10.3%
0.0%
3 Years
-68.26%
1.4%
-6.2%

Evotec Se - Adr Key Stats

Check Evotec Se - Adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.17
Open
$4.06
Today's High
$4.06
Today's Low
$3.98
Market Capitalization
$1.5B
Today's Volume
$26.5K
52 Week High
$5.6405
52 Week Low
$2.84
Revenue TTM
$788.2M
EBITDA
$1.2M
Earnings Per Share (EPS)
$-0.69
Profit Margin
-26.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-20.51%

Stock Returns calculator for Evotec Se - Adr Stock including INR - Dollar returns

The Evotec Se - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evotec Se - Adr investment value today

Current value as on today

₹90,583

Returns

₹9,417

(-9.42%)

Returns from Evotec Se - Adr Stock

₹14,039 (-14.04%)

Dollar Returns*

₹4,622 (+4.62%)

Indian investors sentiment towards Evotec Se - Adr Stock

42%

Period: Jul 1, 2025 to Jul 31, 2025. Change in 30 Days versus previous period

Search interest for Evotec Se - Adr Stock from India on INDmoney has increased by 42% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Evotec Se - Adr

  • Name

    Holdings %

  • Mubadala Investment Company PJSC

    1.29%

  • Wellington Management Company LLP

    0.54%

  • BlackRock Inc

    0.43%

  • DCF Advisers, LLC

    0.21%

  • Morgan Stanley - Brokerage Accounts

    0.02%

  • ABC arbitrage SA

    0.02%

Analyst Recommendation on Evotec Se - Adr Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Evotec Se - Adr(by analysts ranked 0 to 5 stars)

Evotec Se - Adr Share Price Target

What analysts predicted

Upside of 49.54%

Target:

$5.95

Current:

$3.98

Evotec Se - Adr share price target is $5.95, a slight Upside of 49.54% compared to current price of $3.98 as per analysts' prediction.

Evotec Se - Adr Stock Insights

  • Price Movement

    In the last 7 days, EVO stock has moved up by 3.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 221.22M → 199.97M (in $), with an average decrease of 9.6% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -40.83M → -31.57M (in $), with an average increase of 29.3% per quarter
  • EVO vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 5.4% return, outperforming this stock by 17.6%
  • EVO vs NBIX (3 yr)

    In the last 3 years, Neurocrine Biosciences Inc. has given 37.2% return, outperforming this stock by 104.2%
  • Price to Sales

    ForEVO every $1 of sales, investors are willing to pay $1.9, whereas for Haleon Plc Spon Ads, the investors are paying $3.9 for every $1 of sales.

Evotec Se - Adr Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$833.8M
↑ 1.99%
Net Income
$-205.1M
↑ 133.67%
Net Profit Margin
-24.6%
↓ 13.86%

Evotec Se - Adr Technicals Summary

Sell

Neutral

Buy

Evotec Se - Adr is currently in a neutral trading position according to technical analysis indicators.

Evotec Se - Adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Evotec Se - Adr logo
-0.95%
-6.9%
-12.18%
-68.26%
-81.0%
United Therapeutics Corporation logo
-2.99%
-19.89%
-9.92%
25.26%
58.71%
Haleon Plc Spon Ads logo
-6.81%
0.78%
5.41%
30.87%
30.16%
Zoetis Inc. logo
-6.51%
-13.83%
-17.34%
-17.2%
-3.68%
Neurocrine Biosciences Inc. logo
6.84%
-10.79%
-3.4%
48.6%
11.17%

About Evotec Se - Adr

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just " Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Organization
Evotec Se - Adr
Employees
4766
CEO
Dr. Christian Wojczewski Ph.D.
Industry
Miscellaneous

Key Management of Evotec Se - Adr

NameTitle
Dr. Christian Wojczewski Ph.D.
CEO & Management Board Member
Dr. Cord Dohrmann Ph.D.
Chief Scientific Officer & Member of Management Board
Ms. Aurelie Dalbiez
Chief People Officer & Member of Management Board
Mr. Paul Hitchin
CFO & Member of Management Board
Mr. Volker Braun
Executive VP and Head of Global Investor Relations & ESG
Dr. Christian Dargel
EVP Global Head of Legal & Compliance
Dr. Ian M. Hunneyball
Senior Vice President of Programme Management & Clinical Operations
Dr. David Hallet
Executive Vice President
Uwe Andag
EVP Head of Metabolic Diseases
Ms. Christiane Honisch
SVP Head of Diagnostics

Important FAQs about investing in EVO Stock from India :

How to invest in Evotec Se - Adr Stock (EVO) from India?

It is very easy for Indian residents to invest directly in Evotec Se - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evotec Se - Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Evotec Se - Adr or EVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evotec Se - Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evotec Se - Adr shares which would translate to 0.220 fractional shares of Evotec Se - Adr as of today. Learn more about fractional investing.

Can Indians buy Evotec Se - Adr shares?

Yes, Indians can invest in the Evotec Se - Adr (EVO) from India.

With INDmoney, you can buy Evotec Se - Adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Evotec Se - Adr at zero transaction cost.

How can I buy Evotec Se - Adr shares from India?

It is very easy to buy Evotec Se - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Evotec Se - Adr (EVO) be purchased?

Yes, you can buy fractional shares of Evotec Se - Adr with INDmoney app.

What are the documents required to start investing in Evotec Se - Adr stocks?

To start investing in Evotec Se - Adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Evotec Se - Adr share price today?

Evotec Se - Adr share price today stands at $3.98, Open: $4.31 ; Previous Close: $4.17 ; High: $4.06 ; Low: $3.98 ; 52 Week High: $5.64 ; 52 Week Low: $2.84.

The stock opens at $4.31, after a closing price of $4.17. The stock reached a daily high of $4.06 and a low of $3.98, with a 52-week high of $5.64 and a 52-week low of $2.84.

What are today’s High and Low prices of Evotec Se - Adr Stock (EVO)?

Today’s highest price of Evotec Se - Adr (EVO) is $4.06.

Today’s lowest price of Evotec Se - Adr (EVO) is $3.98.

What is the 52 Week High and Low Range of Evotec Se - Adr Stock (EVO)?

  • 52 Week High

    $5.64

  • 52 Week Low

    $2.84

What are the historical returns of Evotec Se - Adr (EVO)?

  • 1 Month Returns

    -0.95%

  • 3 Months Returns

    -6.9%

  • 1 Year Returns

    -12.18%

  • 5 Years Returns

    -81%

What is today's market capitalisation of Evotec Se - Adr?

Today's market capitalisation of Evotec Se - Adr EVO is 1.5B

Who is the Chief Executive Officer (CEO) of Evotec Se - Adr ?

Dr. Christian Wojczewski Ph.D. is the current Chief Executive Officer (CEO) of Evotec Se - Adr.